Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy

Marta Colaneri,Nicolò Amarasinghe,Leonardo Rezzonico, Teresa Chiara Pieri, Emilio Segalini,Margherita Sambo,Silvia Roda,Federica Meloni,Marilena Gregorini,Teresa Rampino,Stefano Pelenghi,Alessandra Ricciardi,Raffaele Bruno

International Journal of Infectious Diseases（2022）

引用 12|浏览9

暂无评分

摘要

•Pre-emptive 3-day course remdesivir might reduce hospitalization due to COVID-19•Data on the effectiveness of this strategy in patients with COVID-19 who received solid organ transplant are lacking•Patients receiving solid organ transplant who received and did not receive pre-emptive remdesivir were evaluated•28-day hospitalization due to COVID-19 was the primary outcome•Remdesivir was effective in reducing hospitalization among patients with COVID-19 who received solid organ transplant

查看译文

关键词

COVID-19,Solid organ transplant recipients,3-day course remdesivir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要